ArticleJournal of the American Chemical Society2026
Iron-Catalyzed Dealkenylative Borylation of Alkenes via Ozonolysis.
Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Given the exceptional versatility of boronic esters as synthetic linchpins, strategies that directly transform naturally abundant motifs such as alkenes into boron-containing intermediates offer substantial value. Herein, we report the development of a dealkenylative borylation transformation that converts C(sp3)-C(sp2) bonds into C(sp3)-B bonds via ozonolysis and iron catalysis. This protocol proceeds efficiently while tolerating a broad range of functional groups. Mechanistic studies indicate that the borylation reagent bis(catecholato)diborane (B2cat2) serves a dual purpose as both the boron source and the stoichiometric reductant. We demonstrate synthetic utility by applying this dealkenylative borylation reaction directly to naturally occurring steroids, terpenes, and terpenoids, as well as to the synthesis of natural products. Finally, the potential of our alkene-to-boron transformation to rapidly access structurally diverse analogues from feedstock compounds is highlighted through the divergent functionalization of the alkene-containing natural product betulinic acid.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.